Health Care • Biotechnology: Pharmaceutical Preparations
$153.67 ▼ -1.07
(-0.69%)
MKT CAP: $6.23B • VOL: 114.9K
52W L $102 52W H $200
ROARABLE / RQD
D- • 36/100
PIOTROSKI
2 / 9
CONSENSUS RATING DISTRIBUTION (40 DESKS)
BUY: 30 HOLD: 8
SELL: 2
12M STREET TARGET RANGE
IMPLIED: +14.0%
LOW
$129
MEDIAN
$172
MEAN
$175
HIGH
$209
STREET BS CREDIBILITY SCORE 1Y BACKTESTED
68/100
EMPIRICAL HIT RATE VS SPOT
GRADES WHETHER SELL-SIDE TARGET REVISIONS LEAD OR CHASE BLTE TAPE
BLTE // FIRM-BY-FIRM ANALYST BACKTEST & BS DETECTOR (ANR <GO>)
CURRENT 90D STREET CONSENSUS
| INSTITUTION / ANALYST | ACTION | RATING | TARGET | PRIOR PT | CALL DATE | PX AT CALL | RET SINCE CALL | 1Y ACCURACY | BS GRADE |
|---|---|---|---|---|---|---|---|---|---|
| Morgan Stanley Institutional Equity Desk | REITERATE | OUTPERFORM | $185.94 | $176.72 | 2025-02-14 | $139.84 | +9.9% | 78% | A |
| Goldman Sachs Global Research Sector Coverage | TARGET REV | STRONG BUY | $193.62 | $181.33 | 2025-02-06 | $144.45 | +6.4% | 74% | A |
| J.P. Morgan Securities US Large Cap | REITERATE | BUY | $175.18 | $169.04 | 2025-01-29 | $147.52 | +4.2% | 67% | B |
| Bernstein Autonomous Forensic Coverage | INITIATE | HOLD | $156.74 | — | 2025-01-17 | $150.60 | +2.0% | 61% | B |
| Barclays Capital Americas Research | DOWNGRADE | UNDERPERFORM | $135.23 | $145.99 | 2025-01-09 | $136.77 | -11.2% | 42% | D |
| UBS Investment Bank Institutional Desk | UPGRADE | BUY | $182.87 | $159.82 | 2024-12-18 | $133.69 | +14.9% | 72% | A |
| Citigroup Global Markets Sector Lead | TARGET REV | HOLD | $149.06 | $155.21 | 2024-12-04 | $142.91 | -4.3% | 48% | C |